83 related articles for article (PubMed ID: 16924499)
1. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1.
Long J; Manchandia T; Ban K; Gao S; Miller C; Chandra J
Cancer Chemother Pharmacol; 2007 Mar; 59(4):527-35. PubMed ID: 16924499
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
[TBL] [Abstract][Full Text] [Related]
3. Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.
Fer ND; Shoemaker RH; Monks A
J Exp Clin Cancer Res; 2010 Jul; 29(1):91. PubMed ID: 20618971
[TBL] [Abstract][Full Text] [Related]
4. Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
Chandra J; Hackbarth J; Le S; Loegering D; Bone N; Bruzek LM; Narayanan VL; Adjei AA; Kay NE; Tefferi A; Karp JE; Sausville EA; Kaufmann SH
Blood; 2003 Dec; 102(13):4512-9. PubMed ID: 12920036
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis identifies oxidative stress induction by adaphostin.
Stockwin LH; Bumke MA; Yu SX; Webb SP; Collins JR; Hollingshead MG; Newton DL
Clin Cancer Res; 2007 Jun; 13(12):3667-81. PubMed ID: 17575232
[TBL] [Abstract][Full Text] [Related]
6. Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl.
Dasmahapatra G; Nguyen TK; Dent P; Grant S
Leuk Res; 2006 Oct; 30(10):1263-72. PubMed ID: 16481037
[TBL] [Abstract][Full Text] [Related]
7. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
Shanafelt TD; Lee YK; Bone ND; Strege AK; Narayanan VL; Sausville EA; Geyer SM; Kaufmann SH; Kay NE
Blood; 2005 Mar; 105(5):2099-106. PubMed ID: 15388586
[TBL] [Abstract][Full Text] [Related]
8. Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines.
Barnes DJ; De S; van Hensbergen P; Moravcsik E; Melo JV
Leukemia; 2007 Mar; 21(3):421-6. PubMed ID: 17252018
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling identifies altered intracellular labile iron homeostasis as a contributing factor to the toxicity of adaphostin: decreased vascular endothelial growth factor secretion is independent of hypoxia-inducible factor-1 regulation.
Hose C; Kaur G; Sausville EA; Monks A
Clin Cancer Res; 2005 Sep; 11(17):6370-81. PubMed ID: 16144942
[TBL] [Abstract][Full Text] [Related]
10. Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr/Abl-positive leukaemia cells.
Liu WH; Chang LS
Biochem J; 2011 Nov; 439(3):453-67. PubMed ID: 21745187
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process.
Yu C; Rahmani M; Almenara J; Sausville EA; Dent P; Grant S
Oncogene; 2004 Feb; 23(7):1364-76. PubMed ID: 14647418
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.
Le SB; Hailer MK; Buhrow S; Wang Q; Flatten K; Pediaditakis P; Bible KC; Lewis LD; Sausville EA; Pang YP; Ames MM; Lemasters JJ; Holmuhamedov EL; Kaufmann SH
J Biol Chem; 2007 Mar; 282(12):8860-72. PubMed ID: 17213201
[TBL] [Abstract][Full Text] [Related]
13. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism.
Dasmahapatra G; Rahmani M; Dent P; Grant S
Blood; 2006 Jan; 107(1):232-40. PubMed ID: 16166589
[TBL] [Abstract][Full Text] [Related]
14. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Sánchez Y; Calle C; de Blas E; Aller P
Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of platensic alcohol as an adamantane surrogate in antitumor drug lead adaphostin.
Wen Z; Duan Y; Xiong Y; Huang Y
Bioorg Med Chem Lett; 2021 Sep; 48():128270. PubMed ID: 34284106
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
17. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R
Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
[TBL] [Abstract][Full Text] [Related]
19. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
20. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
